Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
AIM
$0.16
-5.29%
AIM
· AIM ImmunoTech Inc.
$0.16
-0.01 (-5.29%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred losses from operations and operating cash outflows exceeded cash inflows from operating activities for the six months ended June 30, 2026. These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 7, 2026
Market Cap
$5.08M
Shares
30.44M
Volume · Oct 22
397.69K
Avg daily vol (3M)
4.63M
All webcasts
Earnings call · FY2026 Q1
AIM ImmunoTech Inc. (AIM) Q1 2026 Earnings Call
Revenue
$22,000
+37.5% YoY
Diluted EPS
-$0.69
Net income
-$3.02M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 19, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 15, 2026 · complete as-filed document